Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| May 29 |
| CHRS |
| Coherus Oncology, Inc. |
| AGRANT◆ |
| 25,000 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | AGRANT◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | DTOISS◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | DTOISS◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | DTOISS◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CHRS | Coherus Oncology, Inc. | DTOISS◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |